NIH Funding Opportunities
Notice of Clarification on Research Objectives in RFA-AI-15-020 "NIH-PEPFAR Collaboration on Implementation Science for HIV: Towards an AIDS-free Generation (R01)"
Notice NOT-AI-15-034 from the NIH Guide for Grants and Contracts
Wed, 27 May 2015 12:48:50 EST
Notice of Clarification on Research Objectives in RFA-AI-15-021 "NIH-PEPFAR Collaboration on Implementation Science for HIV: Towards an AIDS-free Generation (R21)"
Notice NOT-AI-15-036 from the NIH Guide for Grants and Contracts
Wed, 27 May 2015 12:47:21 EST
Clarifying Publication Reporting Instructions for Research Performance Progress Reports (RPPR) and Renewal Applications
Notice NOT-OD-15-091 from the NIH Guide for Grants and Contracts
Tue, 26 May 2015 12:23:39 EST
Notice of Corrections to PAR-15-172 : Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01)
Notice NOT-TR-15-012 from the NIH Guide for Grants and Contracts
Tue, 26 May 2015 12:14:38 EST
Collaborative Networks to Advance Delirium Research (R24)
Funding Opportunity RFA-AG-16-009 from the NIH Guide for Grants and Contracts. Delirium, defined as an acute impairment of cognition and attention, is a common complication of severe illness and surgery in older adults. It is associated with multiple adverse outcomes including increased morbidity, mortality, functional and cognitive decline, and institutionalization. Delirium remains markedly underdiagnosed.Moreover, the underlying mechanisms, and thereby potential treatment or prevention targets, are inadequately understood, as is prognosis. Addressing important research gaps may improve approaches for appropriate prevention and management, especially as studies of multicomponent interventions suggest that delirium may be at least 30-40% preventable.This FOA is intended to support a collaborative network to advance scientific research on the causes, mechanisms, outcomes, diagnosis, prevention, and treatment of delirium in older adults.
Wed, 27 May 2015 12:31:55 EST
Mucosal Immunology Studies Team (MIST) (U01)
Funding Opportunity RFA-AI-15-023 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from institutions/organizations to participate in a cooperative research group, the Mucosal Immunology Studies Team (MIST), focusing on immune defense mechanisms and immune regulation at mucosal surfaces of the respiratory, gastrointestinal and urogenital tracts. The purpose of this funding opportunity is to break new ground in the understanding of basic mucosal immune defense mechanisms by introducing new ideas, approaches and technologies that address the difficult questions remaining in mucosal immunology.
Tue, 26 May 2015 04:15:41 EST
Harnessing Genome Editing Technologies to Functionally Validate Genetic Variants in Substance Use Disorders (R21/R33)
Funding Opportunity RFA-DA-16-004 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to harness genome or epigenome editing technologies to functionally validate and characterize genetic or epigenetic variants involved in substance use disorders.The purpose is also that the genetic resources generated will be made broadly available to the scientific community to probe more deeply into the neurobiological mechanisms involved in the function of a variant, gene, or pathway and provide critical foundational knowledge for the development of future prevention, diagnostic, and therapeutic strategies.
Wed, 27 May 2015 03:12:44 EST
SBIR E-learning for HAZMAT and Emergency Response (R43/R44)
Funding Opportunity RFA-ES-15-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to further the development of Advanced Technology Training (ATT) products for the health and safety training of hazardous materials (HAZMAT) workers, skilled support personnel, emergency responders in biosafety response and cleanup, community and citizen preparation and resiliency, and for ATT tools to assist inresearch into the acute and long-term health effects of environmental disasters. This also includes thetraining of workers engaged in environmental restoration, waste treatment, and emergency response activities at sites in the U.S. Department of Energy (DOE) nuclear weapons complex. ATT as defined by the Worker Training Program (WTP) includes, but is not limited to, online training, virtual reality, serious gaming, and tools that complement all aspects of training from development to evaluation including advance technologies that enhance, supplement, improve, and provide health and safety training for hazardous materials workers. These products would complement the goals and objectives of the WTP.The major objective of the NIEHS WTP is to prevent work related harm by assisting in the training of workers in how best to protect themselves and their communities from exposure to hazardous materials.The financial support for this initiative comes directly from NIEHS Worker Education and Training Branch SBIR funds.
Tue, 26 May 2015 04:04:53 EST
ISO/IEC 17025:2005 Accreditation for State Food Testing Laboratories (U18)
Funding Opportunity RFA-FD-15-023 from the NIH Guide for Grants and Contracts. The intended outcome of this FOA is for microbiological and chemical food analyses performed on behalf of State manufactured food regulatory programs to be conducted within the scope of an ISO/IEC 17025:2005 accredited laboratory and the goal of achieving a nationally integrated food safety system to be further advanced. This will be accomplished by preparing the primary food testing laboratories for State manufactured food regulatory programs to achieve and maintain ISO/IEC 17025:2005 laboratory accreditation. Currently accredited laboratories will also be prepared for accreditation enhancements. Increased laboratory analyses from ISO/IEC 17025:2005 accredited labs, as would be accomplished through this cooperative agreement, will in effect serve to increase the analytical capacity for FDA and enhance efforts to protect the food supply.
Tue, 26 May 2015 09:29:11 EST
Smokeless Tobacco Reference Products (UC2)
Funding Opportunity RFA-FD-15-026 from the NIH Guide for Grants and Contracts. FDA's CTP is seeking to develop a smokeless tobacco reference products program that will require significant collaboration and research efforts with outside organizations. The selected organization(s) will develop smokeless tobacco reference products representing at minimum two categories of commercially available smokeless tobacco product types to be used for investigational non-clinical purposes by tobacco manufacturers, contract and government laboratories, and academic institutions. FDA's CTP will prioritize the product types.
Tue, 26 May 2015 09:05:04 EST
Fast-Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3)
Funding Opportunity PAR-15-267 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the discovery and development of medications to treat Cannabis Use Disorders (CUDs) using the UG3/UH3 mechanism. The objective is to advance medications toward the ultimate goal of obtaining FDA approval. Advances in understanding the cannabinoid systems and the effects of marijuana on the brain, coupled with the availability of both novel and marketed medications that may be efficacious to treat these disorders, offer unprecedented opportunities to develop safe and effective pharmacotherapies for CUDs.
Tue, 26 May 2015 07:16:31 EST